Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| TEKLA CAPITAL MANAGEMENT LLC | 08-10-2023 | 06-30-2023 | 166 | 2,555,383,183 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| Amgen Inc. | Common | 1 | $136,883,989 | 616,539 | 0.01 | 0.01 | 60,600 | 10.90 | 06-30-2023 |
| Johnson & Johnson | Common | 2 | $119,468,860 | 721,779 | 0.00 | 0.00 | 0 | 0.00 | 06-30-2023 |
| Gilead Sciences, Inc. | Common | 3 | $118,216,440 | 1,533,884 | 0.00 | 0.00 | -26,000 | -1.67 | 06-30-2023 |
| Regeneron Pharmaceuticals, Inc. | Common | 4 | $115,985,290 | 161,418 | 0.00 | 0.00 | 18,365 | 12.84 | 06-30-2023 |
